What is the ticker symbol for Catabasis Pharmaceuticals?

Catabasis Pharmaceuticals trades under the ticker CATB on NASDAQ.

What sector does Catabasis Pharmaceuticals operate in?

Catabasis Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CATB in a portfolio?

PortView shows CATB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Catabasis Pharmaceuticals (CATB) Stock Analysis

NASDAQHealthcareBiotechnology

$8.54-6.97%

1-year price historyRange $8.54 – $9.53

52-week range$8.54

$1.25$10.26

What Catabasis Pharmaceuticals does

Catabasis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic treatments primarily within the United States. Their leading experimental drug, edasalonexent, is an oral small molecule undergoing Phase III clinical trials for Duchenne Muscular Dystrophy (DMD), functioning by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells. Additionally, the company is developing CAT-5571 as a potential treatment for cystic fibrosis. Catabasis also engages in collaborative research, including a preclinical partnership with the Jain Foundation to investigate edasalonexent for dysferlinopathy, and an agreement with the Bill & Melinda Gates Medical Research Institute to study CAT-5571 for both drug-sensitive and drug-resistant tuberculosis. The company was established in 2008 and is based in Boston, Massachusetts.

Key metrics

Market cap

$234.86M

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

1.66

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$8.23

200-day avg

$3.74

52-week high

$10.26

52-week low

$1.25

CEO

Jill Milne

ETFs linked to CATB

Broad-market and Healthcare sector ETFs an investor holding Catabasis Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CATB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CATB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Catabasis Pharmaceuticals?: Catabasis Pharmaceuticals trades under the ticker CATB on NASDAQ.
Which exchange is CATB listed on?: CATB is listed on NASDAQ.
What sector does Catabasis Pharmaceuticals operate in?: Catabasis Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CATB in a portfolio?: PortView shows CATB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.